306 related articles for article (PubMed ID: 4729314)
1. Some thoughts on surgical adjuvant studies in lung cancer.
Carter SK
Cancer Chemother Rep 3; 1973 Mar; 4(2):109-17. PubMed ID: 4729314
[No Abstract] [Full Text] [Related]
2. Initial therapeutic trial of new drugs in lung cancer.
Selawry OS
Cancer Chemother Rep 3; 1973 Mar; 4(2):215-25. PubMed ID: 4729325
[No Abstract] [Full Text] [Related]
3. Recent therapeutic developments in lung cancer.
Hansen HH; Selawry OS
Med Ann Dist Columbia; 1971 Sep; 40(9):580-2. PubMed ID: 4939062
[No Abstract] [Full Text] [Related]
4. Radiotherapy for bronchogenic carcinoma: actual difficulties and plans for the future.
Dana M
Cancer Chemother Rep 3; 1973 Mar; 4(2):153-5. PubMed ID: 4734076
[No Abstract] [Full Text] [Related]
5. Selecting appropriate therapy for bronchial carcinoma.
Shields TW
Geriatrics; 1974 Jul; 29(7):54-60. PubMed ID: 4835739
[No Abstract] [Full Text] [Related]
6. An overview of the status of the nitrosoureas in other tumors.
Carter SK
Cancer Chemother Rep 3; 1973 May; 4(3):35-46. PubMed ID: 4584034
[No Abstract] [Full Text] [Related]
7. Monochemotherapy of bronchogenic carcinoma withs special reference to cell type.
Selawry OS
Cancer Chemother Rep 3; 1973 Mar; 4(2):177-88. PubMed ID: 4277763
[No Abstract] [Full Text] [Related]
8. Treatment of bronchogenic carcinoma with surgery and radiotherapy: the experience of the National Cancer Institute of Milan.
Bucalossi P; Ravasi G; Bozzetti F; Milani F
Cancer Chemother Rep 3; 1973 Mar; 4(2):101-7. PubMed ID: 4729313
[No Abstract] [Full Text] [Related]
9. Preliminary report on the treatment of nonresectable cancer of the lung.
Kaung DT; Wolf J; Hyde L; Zelen M
Cancer Chemother Rep; 1974; 58(3):359-64. PubMed ID: 4276322
[No Abstract] [Full Text] [Related]
10. New agents and combinations in the treatment of bronchogenic carcinoma.
Bodey GP; Gottlieb JA; Livingston R; Frei E
Cancer Chemother Rep 3; 1973 Mar; 4(2):227-9. PubMed ID: 4125740
[No Abstract] [Full Text] [Related]
11. Effects of long-term adjuvant chemotherapy with cyclophosphamide (NSC-26271) for radically resected bronchogenic carcinoma.
Brunner KW; Marthaler T; Müller W
Cancer Chemother Rep 3; 1973 Mar; 4(2):125-32. PubMed ID: 4199643
[No Abstract] [Full Text] [Related]
12. Lung cancer: perspectives and prospects.
Ann Intern Med; 1970 Dec; 73(6):1003-24. PubMed ID: 4336754
[No Abstract] [Full Text] [Related]
13. Chemotherapy as an adjunct to surgery in the treatment of pulmonary malignant disease.
Mountain CF
Acta Chir Belg; 1971 Apr; 70(4):351-64. PubMed ID: 5143081
[No Abstract] [Full Text] [Related]
14. The role of chemotherapy in the treatment of lung cancer.
Selawry OS
Semin Oncol; 1974 Sep; 1(3):259-72. PubMed ID: 4143488
[No Abstract] [Full Text] [Related]
15. Chemotherapeutic studies in bronchogenic carcinoma by the Austrian study group.
Karrer K; Pridun N; Zwintz E
Cancer Chemother Rep 3; 1973 Mar; 4(2):207-13. PubMed ID: 4729324
[No Abstract] [Full Text] [Related]
16. Chemotherapy for lung cancer at the Institute of Experimental and Clinical Oncology, Academy of Medical Sciences, USSR.
Perevodchikova NI; Bychkov MB
Cancer Chemother Rep 3; 1973 Mar; 4(2):251-5. PubMed ID: 4199645
[No Abstract] [Full Text] [Related]
17. [Experience with combined surgical and cytostatic therapy].
Schnetzer J
Z Tuberk Erkr Thoraxorg; 1968; 128(1):200-2. PubMed ID: 5755189
[No Abstract] [Full Text] [Related]
18. Cyclophosphamide (NSC-26271) as adjuvant to radiotherapy in the treatment of unresectable bronchogenic carcinoma.
Host H
Cancer Chemother Rep 3; 1973 Mar; 4(2):161-4. PubMed ID: 4729319
[No Abstract] [Full Text] [Related]
19. Panel report. The surgeon's viewpoint on collaborative research on lung cancer.
Mountain CF
Cancer Chemother Rep 3; 1973 Mar; 4(2):307-9. PubMed ID: 4125745
[No Abstract] [Full Text] [Related]
20. Small-cell bronchogenic carcinoma; advances in treatment.
Bergevin PR
N Y State J Med; 1980 Nov; 80(12):1847-50. PubMed ID: 6262689
[No Abstract] [Full Text] [Related]
[Next] [New Search]
